Pharmaceutical and non-pharmaceutical interventions for controlling the COVID-19 pandemic

Disease spread can be affected by pharmaceutical interventions (such as vaccination) and non-pharmaceutical interventions (such as physical distancing, mask-wearing and contact tracing). Understanding the relationship between disease dynamics and human behaviour is a significant factor to controllin...

Full description

Saved in:
Bibliographic Details
Published inRoyal Society open science Vol. 10; no. 12; p. 230621
Main Authors Molla, Jeta, Farhang-Sardroodi, Suzan, Moyles, Iain R, Heffernan, Jane M
Format Journal Article
LanguageEnglish
Published England The Royal Society 20.12.2023
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Disease spread can be affected by pharmaceutical interventions (such as vaccination) and non-pharmaceutical interventions (such as physical distancing, mask-wearing and contact tracing). Understanding the relationship between disease dynamics and human behaviour is a significant factor to controlling infections. In this work, we propose a compartmental epidemiological model for studying how the infection dynamics of COVID-19 evolves for people with different levels of social distancing, natural immunity and vaccine-induced immunity. Our model recreates the transmission dynamics of COVID-19 in Ontario up to December 2021. Our results indicate that people change their behaviour based on the disease dynamics and mitigation measures. Specifically, they adopt more protective behaviour when mandated social distancing measures are in effect, typically concurrent with a high number of infections. They reduce protective behaviour when vaccination coverage is high or when mandated contact reduction measures are relaxed, typically concurrent with a reduction of infections. We demonstrate that waning of infection and vaccine-induced immunity are important for reproducing disease transmission in autumn 2021.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
Electronic supplementary material is available online at https://doi.org/10.6084/m9.figshare.c.6978773.
Equal contribution as first author.
ISSN:2054-5703
2054-5703
DOI:10.1098/rsos.230621